Background: High-resolution CT (HRCT) scan data on primary ciliary dyskinesia (PCD) related lung disease are scarce. Study objectives: We evaluated the lung disease in children and adults with PCD by a modified Brody composite HRCT scan score to assess the prevalence of the structural abnormalities; to evaluate the correlation among HRCT scan scores, spirometry findings, and clinical data; and to compare the PCD scores with those of age-matched and sex-matched cystic fibrosis (CF) patients. Patients and methods: Twenty PCD patients (age range, 4.6 to 27.5 years) underwent HRCT scanning, spirometry, and deep throat or sputum culture. A modified Brody score was used to assess bronchiectasis, mucous plugging, peribronchial thickening, parenchyma abnormalities, and mosaic perfusion. Results: The total HRCT scan score was 6% of the maximal score (range, 0.5 to 25.5). Subscores were as follows: bronchiectasis, 5.6%; mucous plugging, 5.6%; peribronchial thickening, 8.3%; parenchyma, 3%; and mosaic perfusion, 0%. The prevalence of lung changes were as follows: bronchiectasis, 80%; peribronchial thickening, 80%; mucous plugging, 75%; parenchyma, 65%; and mosaic perfusion, 45%. Sixteen of 19 PCD patients had positive culture findings, and the most common pathogen found was Haemophilus influenzae (84%). The total HRCT scan score was significantly related to age (p ‫؍‬ 0.006), FEV 1 (p ‫؍‬ 0.02), and FVC (p ‫؍‬ 0.02). The bronchiectasis subscore was significantly related to FEV 1 (p ‫؍‬ 0.04) and FVC (p ‫؍‬ 0.03). In CF patients, the total HRCT scan score was significantly higher than that in PCD patients (p ‫؍‬ 0.02). Conclusions: PCD patients show significantly lower pulmonary HRCT scan scores than CF patients. The PCD total and bronchiectasis scores correlate with spirometry findings. The PCD HRCT scan score might be used for longitudinal assessment and/or represent an outcome surrogate in future studies.
P rimary ciliary dyskinesia (PCD) [MIM 242650] is a rare autosomal-recessive disorder of ciliary dysfunction associated with situs viscerum inversus
(Kartagener syndrome) in approximately half of cases. 1 The diagnosis of PCD is based on the demonstration of abnormal ciliary motility and ultrastructural defects of the respiratory cilia. 1, 2 Impaired mucociliary clearance due to defective motility of the cilia represents the hallmark of the condition. 3 Early clinical events are chronic lower airway infection and recurrent upper airway infections; namely, otitis media and purulent rhinosinusitis. 4 The following three lower airway diseases have been described in older children and adults with PCD: pneumonia; bronchiectasis; and asthma. 5 Lung disease in patients with PCD seems to be milder than that observed in patients with cystic fibrosis (CF). 6, 7 CT scanning of the chest, particularly high-resolution CT (HRCT) scanning, has gained importance in severity grading and monitoring of CF lung disease for clinical management and intervention studies. 8 -12 So far, little has been published on CT scan findings in patients with PCD. In one study 13 of adults and children with PCD, an HRCT scan bronchiectasis score appeared to be related to lung function. This scoring system did not include, however, other common abnormalities such as atelectasis, mucous plugging, peribronchial thickening, and hyperinflation. More recently, Jain and coworkers 6 used a composite HRCT scan scoring system that was developed in CF patients (ie, the Brody score) to describe the chest CT scan findings in children with PCD. 14 This study did not evaluate the relationships between CT score and clinical or functional data.
We report herein a study of structural lung disease in PCD patients using a modified Brody composite HRCT scan scoring system to evaluate the severity and distribution of lung abnormalities in children and adults with PCD. We aimed to assess the prevalence of the various abnormalities, to evaluate the correlations between the HRCT scan score and pulmonary function parameters and clinical data, and to compare the HRCT scan scores of PCD patients with those of age-matched and sex-matched CF patients.
Materials and Methods

Patients
Twenty patients (13 male patients; median age, 14.3 years; age range, 4.6 to 27.5 years) with PCD attending the departments of Pediatric Pulmonology at Federico II University (Naples, Italy) or Erasmus MC-Sophia Children's Hospital (Rotterdam, the Netherlands) were enrolled into the study. The patients from Rotterdam (n ϭ 9) were retrospectively enrolled. CT scans were obtained to establish the severity of lung disease at some time point during follow-up. The patients from Naples (n ϭ 11) prospectively underwent chest HRCT scans for clinical reasons (ie, because of chronic cough and/or persistent focal abnormality seen on a chest radiograph that was unresponsive to medical treatment). We created the following two subgroups: 14 children (median age, 11.6 years; age range, 4.6 to 16.7 years); and 6 adults (median age, 20.6 years; age range, 18 to 27.5 years). PCD was suspected on the basis of clinical features and/or situs viscerum inversus. 5 Diagnosis was confirmed by light microscopy and electron microscopic ultrastructural analysis of cilia obtained using a nasal brush at a median age of 8.1 years (age range, 0.08 to 17.2 years). Light microscopy revealed dysmotility or immotility in all cases. The clinical characteristics and electron microscopy data for the study population are summarized in Table 1 . In all patients, ongoing treatment consisted of the following: daily airway clearance therapy, which included the inhalation of nebulized saline solution prior to chest physiotherapy; physical exercise; and aggressive treatment of upper and lower airways infections with antibiotic therapy.
The 20 PCD patients were compared to 50 age-matched and sex-matched patients from a previously published cohort of 119 CF patients. 15 For each PCD patient, all CF patients with the same age were matched; for example, every 14-year-old male patient with CF was compared with a 14-year-old male patient with PCD. A detailed presentation of the clinical characteristics, pancreatic status, prevalence of Pseudomonas aeruginosa infec- tion, and pulmonary function data for these 50 CF patients is available in the online supplemental data (see supplementary Table 1 ). The ethics review board of the Medical School, Federico II University approved the prospective PCD study, and informed, written consent was obtained from the parent/legal guardian of each child and from adult patients themselves. The ethics review board of Erasmus MC-Sophia Children's Hospital approved the retrospective analysis, and informed, written consent was waived for the retrospective part of the study.
HRCT Scanning
In Naples, HRCT scans in children were obtained using a beam current of 120 mA, an exposure time of 0.5 s (60 mA), a beam potential of 120 kV from the lung apex to the lung base at 15-mm intervals using 1.25-mm thick slices, and a field of view of 250 mm. In adults, HRCT scans were obtained using a beam current of 160 mA, a 1-s exposure time (160 mA), a beam potential of 120 kV from the lung apex to the lung base at 10-mm intervals using 1.5-mm thick slices, and a field of view of 350 mm. All HRCT scans were reconstructed with a high-spatial frequency algorithm (bone). At Erasmus MC-Sophia Children's Hospital, the CT scanning (Prospeed SX scanner; GE Medical Systems; Milwaukee, WI) parameters were as follows: patient in the supine position; deep breathhold; 1.0-mm thick sections at 10-mm intervals; beam potential of 120 kV; beam current of 60 to 160 mA; scanning time of 1 s; field of view of 350 mm; and a reconstruction algorithm was used (Detail; GE Medical Systems). The CT scanning protocols for the CF patients was similar to those reported for the PCD patients. 15 
HRCT Scan Scoring
All identifying information was removed from the CT scans. We used a scoring system developed by Brody et al 14 for CF, which includes bronchiectasis (central and peripheral), mucous plugging (large airways and small airways), peribronchial thickening (central and peripheral), parenchyma abnormalities, and hyperinflation. We modified this scoring system to assess the hyperinflation by mosaic perfusion pattern since only the findings of inspiratory CT scans were available for our study (see supplementary Table 2 in the online supplementary data). Observations were made on six lobes, with the lingula being regarded separately. In patients with situs viscerum inversus, we considered the lung in which the middle lobar bronchus and the corresponding middle lobe were identified on the CT scan as the right lung. A score was calculated for each abnormality, and these scores were summed to provide a total score for each lobe. The scores for the six lobes were then summed to provide a total HRCT scan score, with a theoretical range from 0 (normal) to 243 (maximal score in all lobes). In practice, the maximal score could not exceed 207, as also explained by Brody and coworkers, 14 since a lobe cannot have more than two thirds involvement from all abnormalities at the same time. For example, when a lobe has more than two thirds involvement from atelectasis, it is not possible to score also a more than two thirds involvement from cysts. Subscores were also calculated for each abnormality by limiting the score to the finding of that abnormality. All scores were normalized to a scale of 0 to 100, representing a percentage of the maximum possible score. A total score of Ͼ 5% was considered to be abnormal, as in a recent CF study. 16 The HRCT scan images were evaluated independently and in a blinded fashion by two radiologists and two pediatric pulmonologists. We analyzed the PCD data using mean the HRCT scan scores and the scores from the most experienced observer (Dr. de Jong), who also scored the CF patients. Since no differences were found in the analysis, the scores presented in the current study are from that observer (Dr. de Jong). This enabled a comparison between CF and PCD scores from the same observer.
Lung Function and Microbiological Evaluation in PCD
Spirometric measurements (FVC and FEV 1 ) were performed at the time of HRCT scans according to American Thoracic Society criteria. 17 An FEV 1 of Ͼ 85% predicted was regarded as normal. Deep throat or sputum cultures were also obtained in 19 of 20 patients at the time of the HRCT scan.
Statistical Analysis
Results are expressed as median and range values. Interobserver agreement of total and specific CT scores was calculated using intraclass correlation coefficients. A coefficient of Ͼ 0.8 represents good agreement. The Mann-Whitney U test was used to compare CT scan total and specific scores, and ages at the time of the CT scan between PCD and CF patients. The comparison between PCD and CF lobar distribution of bronchiectasis was made using the 2 test. In PCD patients, Pearson correlation coefficient and Spearman rank correlation coefficient () assessed correlations among continuous normally distributed (total CT scan scores and functional parameters) and continuous, nonnormally distributed variables, respectively. A two-sided p value of Յ 0.05 was significant. The data were analyzed with a statistical software package (SPSS-PC, version 13.0; SPSS; Chicago, IL).
Results
The prevalences of HRCT scan abnormalities and HRCT scan scores of the PCD study population are shown in Table 2 . Bronchiectasis, mucous plugging, and peribronchial thickening were the most frequent lung changes and showed the highest scores in the entire PCD study population, and in affected children and adults. Fifty percent of the patients showed central mucous plugging, while 70% had peripheral mucous plugging. The median scores of central and peripheral mucous plugging were 1.4% (range, 0 to 16.7%) and 5.6% (range, 0 to 13.3%), respectively. Between-observer agreements for HRCT scan scoring are summarized in Table 3 . The mean intraclass coefficients for bronchiectasis, parenchyma, and total CT scan score almost reached 0.8, whereas the remaining coefficients were Ͻ 0.7. Lobar distributions of lung changes are shown in Table 4 . The upper lobes were less frequently involved than the lower lobes, lingula, and middle lobe.
Spirometry results were obtained in all PCD patients. The results of deep throat or sputum cultures and of spirometry in PCD patients are presented in Table 5 . The most common pathogen found in both adults and in children was Haemophilus influenzae (67% and 92%, respectively). P aeruginosa was isolated only in two adults. In three cases, no pathogens were cultured.
The total HRCT scan score correlated to FEV 1 (r ϭ Ϫ0.5; p ϭ 0.02) [Fig 1, top, A] and to FVC (r ϭ Ϫ0.5; p ϭ 0.02). Among the subscores, only the bronchiectasis score showed a significant association with FEV 1 (r ϭ Ϫ0.5; p ϭ 0.04) [Fig 1, bottom, B] and with FVC (r ϭ Ϫ0.5; p ϭ 0.03). The total HRCT scan score was significantly related to the age of the patient at the time of the HRCT scan (r ϭ 0.4; p ϭ 0.006). No difference in total HRCT scan score was found in relation to the type of pathogen isolated from deep throat or sputum cultures (p Ͼ 0.05). Eight of 20 PCD patients with a normal FEV 1 had an abnormal HRCT scan score. One of eight patients with a normal HRCT scan score had an abnormal FEV 1 . Figure 2 illustrates two HRCT scans of an 18-year-old woman with PCD who showed severe functional impairment and substantial structural damage.
There was no significant difference in age at the time of CT scanning between CF and PCD patients (14.4 vs 14.3 years, respectively; p ϭ 0.9). In CF patients, the total HRCT scan score was significantly higher than that in PCD patients (13.5% [range, 1.4 to 44.9%] vs 6% [range, 0.5 to 25.5], respectively; p ϭ 0.02). Among subscores, there was a significant difference between CF and PCD patients only for 
Discussion
This study of children and adults with PCD describes a composite HRCT scan scoring system that evaluates the extension and severity of all common structural lung changes associated with PCD. The following are the main findings. There is reasonable agreement between observers for the presented HRCT scan composite score and the bronchiectasis score in PCD patients. The HRCT scan score was able to demonstrate the prevalence and lobar distribution of the disease. The HRCT scan score increased with age and correlated with pulmonary function test results. The HRCT scan findings demonstrated structural lung disease in PCD patients with a normal lung function. Finally, we demonstrated that the modified Brody HRCT scan score was higher in a cohort of age-matched and sexmatched CF patients than in patients with PCD. The ultimate reason to study HRCT scanning in PCD patients is to determine its clinical value and its potential as an outcome parameter, and for that reason an HRCT scan scoring system may be of value. A chest CT scan provides more accurate delineation of the distribution and nature of lung changes in PCD patients relative to chest radiography and spirometry. 18 We know that in PCD patients FEV 1 measured at the time of diagnosis may be reduced by up to 50% in adolescents under 16 years of age and by up to 80% in adults, 19 and that the demonstration of bronchiectasis on an HRCT scan has led to specific management changes in children with chronic pulmonary disorders, including PCD (ie, aggressive use of antibiotics or more intensive chest physiotherapy). 20, 21 In CF patients, it has been shown that CT scan parameters decline more rapidly compared to spirometry findings, 9 -12,14,22 as spirometry reflects the function of the lung as a whole and gives no clues to regional changes. At present, the clinical indications for PCD on chest CT scans and the rate of change in CT scan parameters over time have not been adequately established, and further studies therefore are needed. The outcome of PCD is not universally unfavorable, but the complications of bronchiectasis and severe pulmonary impairment become more prominent with age. 23 While HRCT scan data on the nature, severity, and distribution of PCD-related lung disease are scarce, many HRCT scan studies have been performed in CF patients. 24 -29 No doubt this is due to the milder manifestation of PCD and its lesser occurrence. However, the HRCT scan pattern of lung disease has been illustrated recently in PCD patients. 6, 13 Our results extend the findings from those studies by providing the relationship among the HRCT scan score, and clinical and functional data in children and adults with PCD. We found that bronchiectatic airways were significantly more prevalent in the right upper lobe in CF patients and were significantly more frequent in the lingula in PCD patients, demonstrating the different distributions of irreversible damage in these two diseases. The comparison between the current study and the study by Kennedy et al 13 is limited by the fact that Kennedy et al 13 scored the CT scans using another system. However, both studies 6, 13 found that the middle lobe and the lingula are the lobes that are most affected by PCD bronchiectasis, followed by the lower lobes, while the upper lobes appear relatively spared. 13 The comparison between the current study and the study by Jain et al 6 is limited by the fact that in the latter study only a subgroup of children underwent CT scanning, but the age of this subgroup was not reported separately. The specific subscores in our children are mostly higher than those reported by Jain and colleagues. 6 One could suspect that this might be due to the different ages of the patients.
We found that bronchiectasis, peribronchial thickening, and peripheral mucous plugging were the most common CT scan changes seen in PCD patients, followed by central mucous plugging and parenchymal abnormalities, while mosaic perfusion pattern was less frequently observed. However, it must be noted that the between-observer reproducibility of the mosaic perfusion pattern score was low. We believe that the value of additional expiratory scans in PCD patients and the observer agreement of an airtrapping score needs further study in order to determine whether this enables a more sensitive and reproducible measurement of small airways involvement. The other potentially sensitive marker of early small airway disease in the Brody scoring system is peripheral mucous plugging.
Given the lack of data on PCD lung disease, our study might be important to add to our current knowledge base in this area. However, it is limited by the fact that HRCT scans were obtained for clinical reasons, part of the data acquisition was retrospective, and longitudinal findings were not included. Therefore, we cannot yet provide information on the progression of HRCT scan abnormalities and the natural course of the disease. In our study, the pediatric scanning protocol used at Federico II University was a slightly different protocol than that used at Erasmus MC-Sophia Children's Hospital, with larger gaps between subsequent CT scan images (15 vs 10 mm, respectively). This leads to different sampling of the disease and might cause a slightly lower CT scan score. Finally, we did not include infants. There has been a marked interest in the use of HRCT scanning in infants with CF, since spirometric measurements are not widely available for infants. 30 -32 Whether the scoring system will be reproducible and usable in this age group can therefore not be deduced from the present study. So, further studies including infants are needed.
In this study, we did not extensively discuss the potential risks associated with the radiation from the CT scans, which may become important especially when multiple follow-up studies are obtained in children. Unless appropriate management guidelines are established, the morbidity from PCD can be considerable, from recurrent respiratory infections associated with progressive lung function impairment to chest surgery. 5, 19 Therefore, we urge further research to determine whether HRCT scanning might result in clinical benefits to the affected individual.
Conclusions
This study on PCD pulmonary disease assessed by the modified CF composite HRCT scan score demonstrates that PCD patients show significantly milder lung damage than CF patients. We found a reasonable agreement between observers for the total CT score, and for the bronchiectasis and parenchyma scores. The total CT scan score and the CT scan bronchiectasis score correlate with lung function parameters. The CT scan score can be used in future longitudinal studies to better define the role of HRCT scanning for clinical purposes and as an outcome parameter in PCD patients.
